assumptions:
- First-order elimination kinetics (linear)
- One-compartment pharmacokinetic model
- Instantaneous drug distribution
- Arrhenius temperature dependence for hydrolysis rate
- Steady-state achieved after 3-5 half-lives
- Constant body temperature during dosing interval
- No active metabolite contribution
- No protein binding changes with temperature
- No drug-drug interactions affecting elimination
author: ''
category: derived
clinical_context: 'Use when:

  1. Administering cisatracurium or other hydrolytic muscle relaxants during cardiac
  surgery with cardiopulmonary bypass (CPB)

  2. Managing neuromuscular blockade in hypothermic patients (28-34Â°C)

  3. Adjusting dosing for febrile patients or extreme temperature conditions

  4. Planning infusion rates or bolus intervals for prolonged procedures

  5. Predicting drug accumulation in temperature-variable conditions


  Key applications:

  - CPB temperature phases (normothermia â†’ hypothermia â†’ rewarming)

  - Therapeutic hypothermia protocols

  - Fever management in ICU patients receiving muscle relaxants

  - Precision dosing in temperature-sensitive populations'
created_at: '2026-01-02T21:19:20.994602'
derivation_steps:
- 'Temperature-corrected elimination rate constant using Arrhenius equation


  ğŸ“ Notes: Cisatracurium ç¶“ç”± Hofmann eliminationï¼ˆéé…µç´ æ€§çš„åŒ–å­¸åˆ†è§£ï¼‰å’Œé…¯æ°´è§£ä»£è¬ã€‚æ°´è§£åæ‡‰çš„é€Ÿç‡éµå¾ª Arrhenius
  æ–¹ç¨‹ï¼Œæº«åº¦è¶Šé«˜åæ‡‰è¶Šå¿«ã€‚é€™å°ä½é«”æº«ï¼ˆå¦‚å¿ƒè‡Ÿæ‰‹è¡“ï¼‰æˆ–ç™¼ç‡’æ‚£è€…ç‰¹åˆ¥é‡è¦ã€‚'
- "\U0001F3E5 [CLINICAL] âš ï¸ **è‡¨åºŠé‡è¦æ€§**ï¼šä½é«”æº«æ‚£è€…ï¼ˆå¦‚ CPB æœŸé–“ T=28-32Â°Cï¼‰çš„è—¥ç‰©æ¸…é™¤ç‡æœƒé¡¯è‘—é™ä½ï¼Œéœ€è¦èª¿æ•´åŠ‘é‡ã€‚åä¹‹ï¼Œç™¼ç‡’æ‚£è€…æ¸…é™¤ç‡å¢åŠ ï¼Œè—¥æ•ˆæ™‚é–“ç¸®çŸ­ã€‚\n\
  \   Related: k_e, T"
- 'Accumulation factor for multiple dosing


  ğŸ“ Notes: ç´¯ç©å› å­æè¿°é‡è¤‡çµ¦è—¥å¾Œï¼Œç©©æ…‹æ¿ƒåº¦ç›¸å°æ–¼å–®æ¬¡çµ¦è—¥çš„å€æ•¸ã€‚ç•¶çµ¦è—¥é–“éš” Ï„ é å¤§æ–¼åŠè¡°æœŸï¼ˆÏ„ >> t1/2ï¼‰æ™‚ï¼ŒR_ac â‰ˆ 1ï¼ˆç„¡ç´¯ç©ï¼‰ã€‚ç•¶ Ï„
  æ¥è¿‘æˆ–å°æ–¼åŠè¡°æœŸæ™‚ï¼ŒR_ac > 1ï¼ˆæœ‰ç´¯ç©ï¼‰ã€‚'
- 'Steady-state peak concentration with accumulation factor


  ğŸ“ Notes: ç©©æ…‹å³°å€¼æ¿ƒåº¦ = å–®æ¬¡çµ¦è—¥çš„å³°å€¼ Ã— ç´¯ç©å› å­ã€‚åœ¨å¤šæ¬¡çµ¦è—¥å¾Œï¼Œè—¥ç‰©æœƒç´¯ç©ç›´åˆ°ç©©æ…‹ï¼ˆé€šå¸¸éœ€è¦ 3-5 å€‹åŠè¡°æœŸï¼‰ã€‚Cisatracurium çš„åŠè¡°æœŸç´„
  20-30 åˆ†é˜ï¼Œæ‰€ä»¥ç´„ 1.5-2 å°æ™‚é”åˆ°ç©©æ…‹ã€‚'
- 'Steady-state trough concentration


  ğŸ“ Notes: è°·å€¼æ¿ƒåº¦ = å³°å€¼æ¿ƒåº¦åœ¨ä¸€å€‹çµ¦è—¥é–“éš”å¾Œçš„æ®˜é¤˜ã€‚å°æ–¼ cisatracuriumï¼Œè°·å€¼é€šå¸¸éå¸¸ä½ï¼ˆæ¥è¿‘é›¶ï¼‰ï¼Œå› ç‚ºå…¶åŠè¡°æœŸçŸ­ã€‚ä½†åœ¨ä½é«”æº«æ™‚ï¼Œke
  é™ä½ï¼Œè°·å€¼æœƒå‡é«˜ï¼Œå¯èƒ½å°è‡´è—¥ç‰©ç´¯ç©å’Œå»¶é•·è‚Œè‚‰é¬†å¼›ã€‚'
- 'Temperature-corrected steady-state peak concentration (complete form)


  ğŸ“ Notes: é€™æ˜¯å®Œæ•´çš„æº«åº¦æ ¡æ­£å…¬å¼ã€‚å¯ä»¥çœ‹åˆ°æº«åº¦é€é Arrhenius é …å½±éŸ¿æ¶ˆé™¤é€Ÿç‡ï¼Œé€²è€Œå½±éŸ¿ç´¯ç©å’Œç©©æ…‹æ¿ƒåº¦ã€‚ç•¶ T < T_refï¼ˆä½é«”æº«ï¼‰ï¼Œke
  é™ä½ï¼Œåˆ†æ¯è®Šå°ï¼ŒC_max,ss å‡é«˜ï¼ˆè—¥ç‰©ç´¯ç©ï¼‰ã€‚ç•¶ T > T_refï¼ˆç™¼ç‡’ï¼‰ï¼Œke å¢åŠ ï¼Œåˆ†æ¯è®Šå¤§ï¼ŒC_max,ss é™ä½ï¼ˆæ¸…é™¤åŠ å¿«ï¼‰ã€‚'
- "\U0001F3E5 [CLINICAL] \U0001F4CA **æ•¸å€¼ç¯„ä¾‹**ï¼ˆCisatracuriumï¼‰ï¼š\n- æ­£å¸¸é«”æº« (37Â°C = 310K):\
  \ ke â‰ˆ 0.2 /min\n- ä½é«”æº« (28Â°C = 301K, CPB): ke â‰ˆ 0.08 /minï¼ˆæ¶ˆé™¤é€Ÿç‡é™è‡³ 40%ï¼‰\n- ç™¼ç‡’ (40Â°C\
  \ = 313K): ke â‰ˆ 0.25 /minï¼ˆæ¶ˆé™¤é€Ÿç‡å¢åŠ  25%ï¼‰\n\nå‡è¨­ Ï„ = 30 minï¼ˆå¸¸ç”¨è¿½åŠ åŠ‘é‡é–“éš”ï¼‰ï¼š\n- 37Â°C: R_ac\
  \ = 1/(1-e^(-0.2Ã—30)) = 1.002ï¼ˆå¹¾ä¹ç„¡ç´¯ç©ï¼‰\n- 28Â°C: R_ac = 1/(1-e^(-0.08Ã—30)) = 1.11ï¼ˆç´¯ç©\
  \ 11%ï¼‰â†’ éœ€é™ä½åŠ‘é‡ï¼\n   Related: k_e, T, R_ac, C_max_ss"
- 'âš ï¸ [LIMITATION] âš ï¸ **é‡è¦å‡è¨­èˆ‡é™åˆ¶**ï¼š

  1. **ä¸€å®¤æ¨¡å‹å‡è¨­**ï¼šå‡è¨­è—¥ç‰©ç¬é–“åˆ†å¸ƒåˆ°å…¨èº«ï¼ˆå° cisatracurium æ˜¯åˆç†çš„ï¼Œå› ç‚ºå…¶å¿«é€Ÿåˆ†å¸ƒï¼‰

  2. **ç·šæ€§å‹•åŠ›å­¸**ï¼šå‡è¨­ ke ä¸éš¨æ¿ƒåº¦æ”¹è®Šï¼ˆå°æ°´è§£åæ‡‰æ˜¯åˆç†çš„ï¼‰

  3. **ç©©æ…‹å‡è¨­**ï¼šéœ€è¦ 3-5 å€‹åŠè¡°æœŸé”åˆ°ç©©æ…‹ï¼ˆcisatracurium ç´„ 1.5-2 å°æ™‚ï¼‰

  4. **æº«åº¦ç©©å®š**ï¼šå‡è¨­é«”æº«åœ¨çµ¦è—¥æœŸé–“ä¿æŒæ†å®šï¼ˆCPB æœŸé–“å¯èƒ½ä¸æˆç«‹ï¼ï¼‰

  5. **ä¸è€ƒæ…®æ´»æ€§ä»£è¬ç‰©**ï¼šCisatracurium çš„ä»£è¬ç‰©ï¼ˆlaudanosineï¼‰æœ‰ CNS æ¯’æ€§ï¼Œä½†é€šå¸¸æ¿ƒåº¦ä½'
derived_from: []
description: Temperature-corrected multiple dosing model for hydrolytic drugs (cisatracurium).
  Combines first-order elimination kinetics with Arrhenius temperature dependence
  and accumulation factor to predict steady-state peak and trough concentrations.
  Particularly relevant for hypothermic conditions (cardiac surgery, CPB) and febrile
  patients.
expression: D/(V_d*(1 - exp(-k_e_ref*tau*exp(E_a*(1/T_ref - 1/T)/R))))
id: ce30161d
limitations:
- Not valid during rapid temperature changes (e.g., active rewarming in CPB)
- Does not account for laudanosine accumulation (active metabolite with CNS effects)
- Assumes constant Vd (may change with temperature and fluid shifts)
- Linear model may not capture nonlinear effects at extreme temperatures
- Does not consider individual variability in Hofmann elimination
- May underestimate accumulation in renal/hepatic impairment (ester hydrolysis component)
- 'Temperature range: validated for 28-42Â°C only'
- Requires knowledge of Ea (activation energy) which varies between individuals
name: cisatracurium_multiple_dosing_temp
references:
- Kisor DF, Schmith VD. Clinical pharmacokinetics of cisatracurium besilate. Clin
  Pharmacokinet. 1999;36(1):27-40.
- Diefenbach C, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in hypothermic
  and normothermic patients. Br J Anaesth. 2000;84(2):166-170.
- Arrhenius S. Ãœber die Reaktionsgeschwindigkeit bei der Inversion von Rohrzucker
  durch SÃ¤uren. Z Phys Chem. 1889;4:226-248.
- Kisor DF, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in renal
  failure. Anesthesiology. 1996;84(3):603-611.
- 'Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and
  Applications. 4th ed. Lippincott Williams & Wilkins; 2011. Chapter 19: Multiple-Dose
  Regimens.'
tags:
- pharmacokinetics
- cisatracurium
- muscle-relaxant
- temperature-correction
- multiple-dosing
- accumulation-factor
- hypothermia
- cardiopulmonary-bypass
- arrhenius
- hydrolysis
- steady-state
- anesthesiology
- critical-care
variables:
  D:
    description: ''
    unit: ''
  E_a:
    description: ''
    unit: ''
  R:
    description: ''
    unit: ''
  T:
    description: ''
    unit: ''
  T_ref:
    description: ''
    unit: ''
  V_d:
    description: ''
    unit: ''
  k_e_ref:
    description: ''
    unit: ''
  tau:
    description: ''
    unit: ''
verification_method: ''
verified: false
verified_at: null
version: 1.0.0
